BiomX Inc. (PHGE)

BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $6.89 million. The enterprise value is $6.55 million.

Market Cap	6.89M
Enterprise Value	6.55M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BiomX has 1.53 million shares outstanding. The number of shares has increased by 190.21% in one year.

Current Share Class	1.53M
Shares Outstanding	1.53M
Shares Change (YoY)	+190.21%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	5.02%
Owned by Institutions (%)	17.92%
Float	1.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.66
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.63.

Current Ratio	1.70
Quick Ratio	1.40
Debt / Equity	0.63
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -154.50% and return on invested capital (ROIC) is -63.96%.

Return on Equity (ROE)	-154.50%
Return on Assets (ROA)	-48.05%
Return on Invested Capital (ROIC)	-63.96%
Return on Capital Employed (ROCE)	-158.12%
Revenue Per Employee	n/a
Profits Per Employee	-$655,702
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BiomX has paid $9,000 in taxes.

Income Tax	9,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.48% in the last 52 weeks. The beta is 1.57, so BiomX's price volatility has been higher than the market average.

Beta (5Y)	1.57
52-Week Price Change	-67.48%
50-Day Moving Average	8.69
200-Day Moving Average	9.83
Relative Strength Index (RSI)	30.80
Average Volume (20 Days)	65,216

Short Selling Information

The latest short interest is 33,072, so 2.17% of the outstanding shares have been sold short.

Short Interest	33,072
Short Previous Month	8,689
Short % of Shares Out	2.17%
Short % of Float	3.07%
Short Ratio (days to cover)	0.44

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.11M
Pretax Income	-37.37M
Net Income	-37.38M
EBITDA	-30.42M
EBIT	-33.11M
Earnings Per Share (EPS)	-$28.79

Balance Sheet

The company has $6.92 million in cash and $6.58 million in debt, giving a net cash position of $340,000 or $0.22 per share.

Cash & Cash Equivalents	6.92M
Total Debt	6.58M
Net Cash	340,000
Net Cash Per Share	$0.22
Equity (Book Value)	10.49M
Book Value Per Share	-5.76
Working Capital	3.64M

Cash Flow

In the last 12 months, operating cash flow was -$28.29 million and capital expenditures -$13,000, giving a free cash flow of -$28.31 million.

Operating Cash Flow	-28.29M
Capital Expenditures	-13,000
Free Cash Flow	-28.31M
FCF Per Share	-$18.54

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-190.21%
Shareholder Yield	-190.21%
Earnings Yield	-542.84%
FCF Yield	-411.12%

Analyst Forecast

The average price target for BiomX is $26.00, which is 476.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.00
Price Target Difference	476.50%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-54.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 25, 2025. It was a reverse split with a ratio of 1:19.

Last Split Date	Nov 25, 2025
Split Type	Reverse
Split Ratio	1:19

Scores

Altman Z-Score	n/a
Piotroski F-Score	1